Upper motor neuron and extra-motor neuron involvement in amyotrophic lateral sclerosis: A clinical and brain imaging review

Neuromuscular Disorders

Volumn 19, Issue 1, 2009, Pages 53-58

  van der Graaff, M M ^a   de Jong, J M B V ^a   Baas, F ^a   de Visser, M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Amyotrophic lateral sclerosis; Dementia; Imaging of; Motor neuron disease; Neurobiology of; TDP 43

Indexed keywords

DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL FEATURE; COGNITIVE DEFECT; DIFFUSION TENSOR IMAGING; DISEASE COURSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MORPHOMETRICS; MOTONEURON; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIMARY LATERAL SCLEROSIS; PRIORITY JOURNAL; PROGRESSIVE MUSCULAR ATROPHY; RADIODIAGNOSIS; SENSORY NERVE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AMYOTROPHIC LATERAL SCLEROSIS; AUTONOMIC NERVOUS SYSTEM DISEASES; BRAIN; DEMENTIA; DIAGNOSTIC IMAGING; DNA-BINDING PROTEINS; HUMANS; MOTOR NEURON DISEASE; SPINAL CORD;

EID: 58849124779     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2008.10.002     Document Type: Article

References (91)

1. Brooks BR. El Escorial World federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on motor neuron diseases/amyotrophic lateral sclerosis of the world federation of neurology research group on neuromuscular diseases and the El escorial "clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994;124:96-107.
2. Brooks B.R., Miller R.G., Swash M., and Munsat T.L. El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1 (2000) 293-299
3. Chou S.M., and Norris F.H. Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons. Muscle Nerve 16 (1993) 864-869
4. Eisen A.A. Comment on the lower motor neuron hypothesis. Muscle Nerve 16 (1993) 870-871
5. Eisen A., Kim S., and Pant B. Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron?. Muscle Nerve 15 (1992) 219-224
6. Eisen A., and Weber M. The motor cortex and amyotrophic lateral sclerosis. Muscle Nerve 24 (2001) 564-573
7. Charcot J-M. Troubles trophique consecutifs aux lesions des nerfs; Paris, Bureaux du Progres Medical, 1880, p. 1-32.
8. Pamphlett R., Kril J., and Hng T.M. Motor neuron disease: a primary disorder of corticomotoneurons?. Muscle Nerve 18 (1995) 314-318
9. Pringle C.E., Hudson A.J., Munoz D.G., Kiernan J.A., Brown W.F., and Ebers G.C. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 115 Pt 2 (1992) 495-520
10. Gowers WR. Manual of diseases of the nervous system. ed Reprinted special edition, Birmingham, Alabama, 1981.
11. Abrahams S., Leigh P.N., and Goldstein L.H. Cognitive change in ALS: a prospective study. Neurology 64 (2005) 1222-1226
12. Rippon G.A., Scarmeas N., Gordon P.H., Murphy P.L., Albert S.M., Mitsumoto H., et al. An observational study of cognitive impairment in amyotrophic lateral sclerosis. Arch Neurol 63 (2006) 345-352
13. Bogaert L., and Bertrand I. Pathologic changes of senile type in Charcot's disease. Arch Neurol Psychiatry 16 (1926) 263
14. Wechsler I., and Davison C. Amyotrophic lateral sclerosis with mental symptoms. Arch Neurol Psychiatry 27 (1932) 859
15. Rosenfeld J., and Swash M. What's in a name? Lumping or splitting ALS, PLS, PMA, and the other motor neuron diseases. Neurology 66 (2006) 624-625
16. Gordon P.H., Cheng B., Katz I.B., Pinto M., Hays A.P., Mitsumoto H., et al. The natural history of primary lateral sclerosis. Neurology 66 (2006) 647-653
17. Eisen A., Mezei M.M., Stewart H.G., Fabros M., Gibson G., and Andersen P.M. SOD1 gene mutations in ALS patients from British Columbia, Canada: clinical features, neurophysiology and ethical issues in management. Amyotroph Lateral Scler 9 (2008) 108-119
18. Ravits J., Paul P., and Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 68 (2007) 1571-1575
19. Attarian S., Vedel J.P., Pouget J., and Schmied A. Progression of cortical and spinal dysfunctions over time in amyotrophic lateral sclerosis. Muscle Nerve 37 (2008) 364-375
20. Ravits J., Laurie P., Fan Y., and Moore D.H. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology 68 (2007) 1576-1582
21. Boillee S., Vande V.C., and Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52 (2006) 39-59
22. Boillee S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312 (2006) 1389-1392
23. Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11 (2008) 251-253
24. Monk P.N., and Shaw P.J. ALS: life and death in a bad neighborhood. Nat Med 12 (2006) 885-887
25. Visser J., van den Berg-Vos R.M., Franssen H., Van den Berg L.H., Wokke J.H., de Jong J.M., et al. Disease course and prognostic factors of progressive muscular atrophy. Arch Neurol 64 (2007) 522-528
26. Cosottini M., Giannelli M., Siciliano G., Lazzarotti G., Michelassi M.C., Del C.A., et al. Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. Radiology 237 (2005) 258-264
27. Sach M., Winkler G., Glauche V., Liepert J., Heimbach B., Koch M.A., et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 127 (2004) 340-350
28. Ince P.G., Evans J., Knopp M., Forster G., Hamdalla H.H., Wharton S.B., et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology 60 (2003) 1252-1258
29. Cudkowicz M.E., Kenna-Yasek D., Chen C., Hedley-Whyte E.T., and Brown Jr. R.H. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene. Ann Neurol 43 (1998) 703-710
30. Regal L., Vanopdenbosch L., Tilkin P., Van Den B.L., Thijs V., Sciot R., et al. The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis. Arch Neurol 63 (2006) 262-267
31. Valentino P., Conforti F.L., Pirritano D., Nistico R., Mazzei R., Patitucci A., et al. Brachial amyotrophic diplegia associated with a novel SOD1 mutation (L106P). Neurology 64 (2005) 1477-1478
32. Charcot J.-M. Sclérose des cordons latéraux de la moelle épiniére chez une femme hystérique atteinte de contracture permanente des quatre members. Bull Soc Med Hop Paris 2 suppl 2 (1865) 24-42
33. Brugman F., Wokke J.H., Vianney de Jong J.M., Franssen H., Faber C.G., and Van den Berg L.H. Primary lateral sclerosis as a phenotypic manifestation of familial ALS. Neurology 64 (2005) 1778-1779
34. Le F.N., Maisonobe T., Spelle L., Lesort A., Salachas F., Lacomblez L., et al. Primary lateral sclerosis: further clarification. J Neurol Sci 185 (2001) 95-100
35. Strong M.J., and Gordon P.H. Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: discrete entities or spectrum?. Amyotroph Lateral Scler Other Motor Neuron Disord 6 (2005) 8-16
36. Hecht M.J., Fellner F., Fellner C., Hilz M.J., Heuss D., and Neundorfer B. MRI-FLAIR images of the head show corticospinal tract alterations in ALS patients more frequently than T2-, T1- and proton-density-weighted images. J Neurol Sci 186 (2001) 37-44
37. Hecht M.J., Fellner F., Fellner C., Hilz M.J., Neundorfer B., and Heuss D. Hyperintense and hypointense MRI signals of the precentral gyrus and corticospinal tract in ALS: a follow-up examination including FLAIR images. J Neurol Sci 199 (2002) 59-65
38. Peretti-Viton P., Azulay J.P., Trefouret S., Brunel H., Daniel C., Viton J.M., et al. MRI of the intracranial corticospinal tracts in amyotrophic and primary lateral sclerosis. Neuroradiology 41 (1999) 744-749
39. Iwata N.K., Aoki S., Okabe S., Arai N., Terao Y., Kwak S., et al. Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation. Neurology 70 (2008) 528-532
40. Mori S., Crain B.J., Chacko V.P., and van Zijl P.C. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 45 (1999) 265-269
41. Abe O., Yamada H., Masutani Y., Aoki S., Kunimatsu A., Yamasue H., et al. Amyotrophic lateral sclerosis: diffusion tensor tractography and voxel-based analysis. NMR Biomed 17 (2004) 411-416
42. Aoki S., Iwata N.K., Masutani Y., Yoshida M., Abe O., Ugawa Y., et al. Quantitative evaluation of the pyramidal tract segmented by diffusion tensor tractography: feasibility study in patients with amyotrophic lateral sclerosis. Radiat Med 23 (2005) 195-199
43. Hong Y.H., Lee K.W., Sung J.J., Chang K.H., and Song I.C. Diffusion tensor MRI as a diagnostic tool of upper motor neuron involvement in amyotrophic lateral sclerosis. J Neurol Sci 227 (2004) 73-78
44. Karlsborg M., Rosenbaum S., Wiegell M., Simonsen H., Larsson H., Werdelin L., et al. Corticospinal tract degeneration and possible pathogenesis in ALS evaluated by MR diffusion tensor imaging. Amyotroph Lateral Scler Other Motor Neuron Disord 5 (2004) 136-140
45. Toosy A.T., Werring D.J., Orrell R.W., Howard R.S., King M.D., Barker G.J., et al. Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 74 (2003) 1250-1257
46. Wang S., and Melhem E.R. Amyotrophic lateral sclerosis and primary lateral sclerosis: the role of diffusion tensor imaging and other advanced mr-based techniques as objective upper motor neuron markers. Ann NY Acad Sci 1064 (2005) 61-77
47. Block W., Karitzky J., Traber F., Pohl C., Keller E., Mundegar R.R., et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol 55 (1998) 931-936
48. Chan S., Shungu D.C., Douglas-Akinwande A., Lange D.J., and Rowland L.P. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology 212 (1999) 763-769
49. Gredal O., Rosenbaum S., Topp S., Karlsborg M., Strange P., and Werdelin L. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 48 (1997) 878-881
50. Suhy J., Miller R.G., Rule R., Schuff N., Licht J., Dronsky V., et al. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology 58 (2002) 773-779
51. Pohl C., Block W., Karitzky J., Traber F., Schmidt S., Grothe C., et al. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol 58 (2001) 729-735
52. Unrath A., Ludolph A.C., and Kassubek J. Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study. J Neurol 254 (2007) 1099-1106
53. Bowen B.C., Pattany P.M., Bradley W.G., Murdoch J.B., Rotta F., Younis A.A., et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 21 (2000) 647-658
54. Kalra S., Vitale A., Cashman N.R., Genge A., and Arnold D.L. Cerebral degeneration predicts survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 77 (2006) 1253-1255
55. Portet F., Cadilhac C., Touchon J., and Camu W. Cognitive impairment in motor neuron disease with bulbar onset. Amyotroph Lateral Scler Other Motor Neuron Disord 2 (2001) 23-29
56. Ringholz G.M., Appel S.H., Bradshaw M., Cooke N.A., Mosnik D.M., and Schulz P.E. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65 (2005) 586-590
57. Murphy J.M., Henry R.G., Langmore S., Kramer J.H., Miller B.L., and Lomen-Hoerth C. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 64 (2007) 530-534
58. Lipton A.M., White III C.L., and Bigio E.H. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol (Berl) 108 (2004) 379-385
59. Mackenzie I.R. The Neuropathology of FTD Associated With ALS. Alzheimer Dis Assoc Disord 21 (2007) S44-S49
60. Morita M., Al-Chalabi A., Andersen P.M., Hosler B., Sapp P., Englund E., et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 66 (2006) 839-844
61. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006) 130-133
62. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351 (2006) 602-611
63. Dickson D.W., Josephs K.A., and mador-Ortiz C. TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol (Berl) 114 (2007) 71-79
64. Mackenzie I.R., Bigio E.H., Ince P.G., Geser F., Neumann M., Cairns N.J., et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61 (2007) 427-434
65. Geser F., Brandmeir N.J., Kwong L.K., Martinez-Lage M., Elman L., McCluskey L., et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 65 (2008) 636-641
66. Amador-Ortiz C., Lin W.L., Ahmed Z., Personett D., Davies P., Duara R., et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61 (2007) 435-445
67. Foulds P., McAuley E., Gibbons L., Davidson Y., Pickering-Brown S.M., Neary D., et al. TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration. Acta Neuropathol 116 (2008) 141-146
68. Josephs K.A., Whitwell J.L., Knopman D.S., Hu W.T., Stroh D.A., Baker M., et al. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 70 (2008) 1850-1857
69. Forman M.S., Trojanowski J.Q., and Lee V.M. TDP-43: a novel neurodegenerative proteinopathy. Curr Opin Neurobiol 17 (2007) 548-555
70. Kwong L.K., Uryu K., Trojanowski J.Q., and Lee V.M. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis. Neurosignals 16 (2008) 41-51
71. Uryu K., Nakashima-Yasuda H., Forman M.S., Kwong L.K., Clark C.M., Grossman M., et al. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other Tauopathies. J Neuropathol Exp Neurol 67 (2008) 555-564
72. Tan C.F., Eguchi H., Tagawa A., Onodera O., Iwasaki T., Tsujino A., et al. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol 113 (2007) 535-542
73. Robertson J., Sanelli T., Xiao S., Yang W., Horne P., Hammond R., et al. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS. Neurosci Lett 420 (2007) 128-132
74. Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande V.C., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40 (2008) 572-574
75. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319 (2008) 1668-1672
76. Lloyd C.M., Richardson M.P., Brooks D.J., Al-Chalabi A., and Leigh P.N. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain 123 Pt 11 (2000) 2289-2296
77. Turner M.R., Rabiner E.A., Hammers A., Al-Chalabi A., Grasby P.M., Shaw C.E., et al. [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. Brain 128 (2005) 896-905
78. Abrahams S., Goldstein L.H., Kew J.J., Brooks D.J., Lloyd C.M., Frith C.D., et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain 119 Pt 6 (1996) 2105-2120
79. Waragai M., Takaya Y., and Hayashi M. Serial MRI and SPECT in amyotrophic lateral sclerosis: a case report. J Neurol Sci 148 (1997) 117-1120
80. Borasio G.D., Linke R., Schwarz J., Schlamp V., Abel A., Mozley P.D., et al. Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography. J Neurol Neurosurg Psychiatry 65 (1998) 263-265
81. Abrahams S., Goldstein L.H., Simmons A., Brammer M., Williams S.C., Giampietro V., et al. Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain 127 (2004) 1507-1517
82. Stanton B.R., Williams V.C., Leigh P.N., Williams S.C., Blain C.R., Jarosz J.M., et al. Altered cortical activation during a motor task in ALS. Evidence for involvement of central pathways. J Neurol 254 (2007) 1260-1267
83. Abrahams S., Goldstein L.H., Suckling J., Ng V., Simmons A., Chitnis X., et al. Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol 252 (2005) 321-331
84. Grosskreutz J., Kaufmann J., Fradrich J., Dengler R., Heinze H.J., and Peschel T. Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis. BMC Neurol 6 (2006) 17
85. Kassubek J., Unrath A., Huppertz H.J., Lule D., Ethofer T., Sperfeld A.D., et al. Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotroph Lateral Scler Other Motor Neuron Disord 6 (2005) 213-220
86. Baltadzhieva R., Gurevich T., and Korczyn A.D. Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol 18 (2005) 487-493
87. Karlsborg M., Andersen E.B., Wiinberg N., Gredal O., Jorgensen L., and Mehlsen J. Sympathetic dysfunction of central origin in patients with ALS. Eur J Neurol 10 (2003) 229-234
88. Asai H., Hirano M., Udaka F., Shimada K., Oda M., Kubori T., et al. Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALS. J Neurol Sci 254 (2007) 78-83
89. Shimizu T., Kawata A., Kato S., Hayashi M., Takamoto K., Hayashi H., et al. Autonomic failure in ALS with a novel SOD1 gene mutation. Neurology 54 (2000) 1534-1537
90. Hammad M., Silva A., Glass J., Sladky J.T., and Benatar M. Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology 69 (2007) 2236-2242
91. Pugdahl K., Fuglsang-Frederiksen A., de C.M., Johnsen B., Fawcett P.R., Labarre-Vila A., et al. Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study. J Neurol Neurosurg Psychiatry 78 (2007) 746-749